- Home
- YMAB vs QSI Comparison
YMAB vs QSI Comparison
Compare YMAB & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- QSI
- Stock Information
- Founded
- YMAB 2015
- QSI 2013
- Country
- YMAB United States
- QSI United States
- Employees
- YMAB N/A
- QSI N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- YMAB Health Care
- QSI Health Care
- Exchange
- YMAB Nasdaq
- QSI Nasdaq
- Market Cap
- YMAB 218.4M
- QSI 214.3M
- IPO Year
- YMAB 2018
- QSI N/A
- Fundamental
- Price
- YMAB $4.69
- QSI $1.15
- Analyst Decision
- YMAB Buy
- QSI Strong Buy
- Analyst Count
- YMAB 11
- QSI 3
- Target Price
- YMAB $18.73
- QSI $3.42
- AVG Volume (30 Days)
- YMAB 318.1K
- QSI 3.9M
- Earning Date
- YMAB 05-06-2025
- QSI 05-08-2025
- Dividend Yield
- YMAB N/A
- QSI N/A
- EPS Growth
- YMAB N/A
- QSI N/A
- EPS
- YMAB N/A
- QSI N/A
- Revenue
- YMAB $87,685,000.00
- QSI $3,058,000.00
- Revenue This Year
- YMAB N/A
- QSI $151.18
- Revenue Next Year
- YMAB $21.10
- QSI $172.07
- P/E Ratio
- YMAB N/A
- QSI N/A
- Revenue Growth
- YMAB 3.38
- QSI 182.63
- 52 Week Low
- YMAB $3.86
- QSI $0.61
- 52 Week High
- YMAB $17.78
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- YMAB 47.75
- QSI 40.89
- Support Level
- YMAB $4.46
- QSI $1.11
- Resistance Level
- YMAB $5.44
- QSI $1.31
- Average True Range (ATR)
- YMAB 0.45
- QSI 0.10
- MACD
- YMAB 0.07
- QSI 0.01
- Stochastic Oscillator
- YMAB 52.53
- QSI 45.61
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.